Approval · Notice of Compliance 8915 · 2007
TRANDATE: Notice of Compliance 8915
Issued July 18, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8915
- Date
- July 18, 2007
- Company
- Squire Pharmaceuticals Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antihypertensive agent
Products in this notice
Medicinal ingredients
- LABETALOL HCL 100 MG per TAB
- LABETALOL HCL 200 MG per TAB